Viatris (VTRS) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Viatris Revenue Highlights

Latest Revenue (Y)

$15.43B

Latest Revenue (Q)

$3.74B

Main Segment (Y)

Brands

Main Geography (Y)

Developed Markets Segment

Viatris Revenue by Period

Viatris Revenue by Year

Date	Revenue	Change
2023-12-31	$15.43B	-5.14%
2022-12-31	$16.26B	-9.08%
2021-12-31	$17.89B	49.73%
2020-12-31	$11.95B	3.87%
2019-12-31	$11.50B	0.58%
2018-12-31	$11.43B	-3.98%
2017-12-31	$11.91B	7.50%
2016-12-31	$11.08B	17.47%
2015-12-31	$9.43B	22.15%
2014-12-31	$7.72B	11.73%
2013-12-31	$6.91B	1.66%
2012-12-31	$6.80B	10.87%
2011-12-31	$6.13B	12.46%
2010-12-31	$5.45B	7.02%
2009-12-31	$5.09B	-0.87%
2008-12-31	$5.14B	218.74%
2007-03-31	$1.61B	28.21%
2006-03-31	$1.26B	0.30%
2005-03-31	$1.25B	-8.82%
2004-03-31	$1.37B	8.31%
2003-03-31	$1.27B	14.96%
2002-03-31	$1.10B	30.40%
2001-03-31	$846.70M	7.16%
2000-03-31	$790.14M	9.57%
1999-03-31	$721.10M	36.42%
1998-03-31	$528.60M	20.08%
1997-03-31	$440.20M	12.04%
1996-03-31	$392.90M	-0.81%
1995-03-31	$396.10M	57.31%
1994-03-31	$251.80M	18.77%
1993-03-31	$212.00M	-

Viatris generated $15.43B in revenue during NA 2023, up -5.14% compared to the previous quarter, and up 134.92% compared to the same period a year ago.

Viatris Revenue by Quarter

Date	Revenue	Change
2024-09-30	$3.74B	-1.54%
2024-06-30	$3.80B	3.64%
2024-03-31	$3.66B	-4.53%
2023-12-31	$3.84B	-2.65%
2023-09-30	$3.94B	0.59%
2023-06-30	$3.92B	5.08%
2023-03-31	$3.73B	-3.79%
2022-12-31	$3.88B	-4.96%
2022-09-30	$4.08B	-0.94%
2022-06-30	$4.12B	-1.79%
2022-03-31	$4.19B	-3.45%
2021-12-31	$4.34B	-4.30%
2021-09-30	$4.54B	-0.90%
2021-06-30	$4.58B	3.33%
2021-03-31	$4.43B	22.27%
2020-12-31	$3.62B	21.92%
2020-09-27	$2.97B	8.82%
2020-06-28	$2.73B	4.28%
2020-03-29	$2.62B	-17.94%
2019-12-31	$3.19B	7.77%
2019-09-29	$2.96B	3.86%
2019-06-29	$2.85B	14.27%
2019-03-30	$2.50B	-18.94%
2018-12-30	$3.08B	7.56%
2018-09-29	$2.86B	1.93%
2018-06-29	$2.81B	4.61%
2018-03-30	$2.68B	-17.12%
2017-12-30	$3.24B	8.43%
2017-09-29	$2.99B	0.84%
2017-06-29	$2.96B	8.92%
2017-03-30	$2.72B	-16.78%
2016-12-31	$3.27B	6.89%
2016-09-30	$3.06B	19.39%
2016-06-30	$2.56B	16.86%
2016-03-31	$2.19B	-12.02%
2015-12-31	$2.49B	-7.59%
2015-09-30	$2.70B	13.64%
2015-06-30	$2.37B	26.71%
2015-03-31	$1.87B	-10.13%
2014-12-31	$2.08B	-0.06%
2014-09-30	$2.08B	13.43%
2014-06-30	$1.84B	7.09%
2014-03-31	$1.72B	-5.14%
2013-12-31	$1.81B	2.33%
2013-09-30	$1.77B	3.86%
2013-06-30	$1.70B	4.30%
2013-03-31	$1.63B	-4.16%
2012-12-31	$1.70B	-5.93%
2012-09-30	$1.81B	6.99%
2012-06-30	$1.69B	6.23%
2012-03-31	$1.59B	4.00%
2011-12-31	$1.53B	-2.83%
2011-09-30	$1.58B	0.12%
2011-06-30	$1.57B	8.62%
2011-03-31	$1.45B	1.01%
2010-12-31	$1.43B	5.86%
2010-09-30	$1.36B	-0.98%
2010-06-30	$1.37B	5.89%
2010-03-31	$1.29B	-4.40%
2009-12-31	$1.35B	6.94%
2009-09-30	$1.26B	-0.23%
2009-06-30	$1.27B	4.72%
2009-03-31	$1.21B	0.56%
2008-12-31	$1.20B	-27.38%
2008-09-30	$1.66B	37.71%
2008-06-30	$1.20B	11.97%
2008-03-31	$1.07B	-

Viatris generated $3.74B in revenue during Q3 2024, up -1.54% compared to the previous quarter, and up 95.39% compared to the same period a year ago.

Viatris Revenue Breakdown

Viatris Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 23	Dec 22	Dec 21	Dec 20
Generics	$5.59B	$5.02B	-	-
Brands	$9.80B	$9.89B	-	-
Complex GX and Biosimilars	-	$1.31B	-	-
Product	-	$16.22B	$17.81B	-
Product and Service, Other	-	-	-	$126.10M

Viatris's latest annual revenue breakdown by segment (product or service), as of Dec 23: Brands (63.69%), and Generics (36.31%).

Quarterly Revenue by Product

Product/Service	Sep 24	Mar 24	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21
Generics	$1.38B	$1.34B	$1.23B	-	-	-	-	-	-	-	-	-	-
Brands	$2.36B	$2.31B	$2.53B	-	-	-	-	-	-	-	-	-	-
Xalabrands	-	$42.50M	$47.90M	$48.40M	$54.00M	$55.80M	$58.30M	$57.90M	-	-	-	-	-
Product and Service, Other	-	-	-	$9.10M	$10.00M	$8.90M	$10.80M	$11.40M	$13.50M	-	-	-	-

Viatris's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Brands (63.19%), and Generics (36.81%).

Viatris Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 23	Dec 22	Dec 21	Dec 20
Developed Markets Segment	$9.25B	$9.77B	-	-
Japan, Australia and New Zealand Segment	$1.42B	$1.63B	-	-
Emerging Markets Segment	$2.55B	$2.62B	-	-
Greater China Segment	$2.16B	$2.20B	-	-
CHINA	-	$1.95B	$1.98B	-
UNITED STATES	-	$3.95B	$4.18B	$3.75B
FRANCE	-	-	-	$1.07B
INDIA	-	-	-	$1.16B

Viatris's latest annual revenue breakdown by geography, as of Dec 23: Developed Markets Segment (60.12%), Emerging Markets Segment (16.58%), Greater China Segment (14.04%), and Japan, Australia and New Zealand Segment (9.26%).

Quarterly Revenue by Country

Country	Sep 24	Mar 24	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21
Emerging Markets Segment	$533.20M	$626.40M	-	-	-	-	-	-	-	-	-	-	-
Developed Markets Segment	$2.30B	$2.17B	-	-	-	-	-	-	-	-	-	-	-
Greater China Segment	$561.80M	$543.90M	$548.40M	$1.60M	$2.20M	$100.00K	$1.90M	$1.70M	$3.40M	$2.70M	-	$1.10M	$1.00M
Japan, Australia and New Zealand Segment	$344.30M	$317.80M	-	-	-	-	-	-	-	-	-	-	-

Viatris's latest quarterly revenue breakdown by geography, as of Sep 24: Developed Markets Segment (61.50%), Greater China Segment (15.03%), Emerging Markets Segment (14.26%), and Japan, Australia and New Zealand Segment (9.21%).

Viatris Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
TAK	Takeda Pharmaceutical Company	$4.26T	$1.05T
RDY	Dr. Reddy's Laboratories	$279.16B	-
TEVA	Teva Pharmaceutical Industries	$15.85B	$4.33B
VTRS	Viatris	$15.43B	$3.74B
HLN	Haleon	$11.30B	$2.92B
BHC	Bausch Health Companies	$8.76B	$2.51B
ZTS	Zoetis	$8.54B	$2.39B
ELAN	Elanco Animal Health	$4.42B	$1.18B
CTLT	Catalent	$4.38B	$1.02B
LNTH	Lantheus	$1.30B	$378.73M
EBS	Emergent BioSolutions	$1.05B	$254.70M
HCM	HUTCHMED (China)	$838.00M	$152.56M
TLRY	Tilray Brands	$788.94M	$200.04M

VTRS Revenue FAQ

What is Viatris’s yearly revenue?

Viatris's yearly revenue for 2023 was $15.43B, representing a decrease of -5.14% compared to 2022. The company's yearly revenue for 2022 was $16.26B, representing a decrease of -9.08% compared to 2021. VTRS's yearly revenue for 2021 was $17.89B, representing an increase of 49.73% compared to 2020.

What is Viatris’s quarterly revenue?

Viatris's quarterly revenue for Q3 2024 was $3.74B, a -1.54% decrease from the previous quarter (Q2 2024), and a -5.17% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $3.8B, a 3.64% increase from the previous quarter (Q1 2024), and a -3.11% decrease year-over-year (Q2 2023). VTRS's quarterly revenue for Q1 2024 was $3.66B, a -4.53% decrease from the previous quarter (Q4 2023), and a -1.76% decrease year-over-year (Q1 2023).

What is Viatris’s revenue growth rate?

Viatris's revenue growth rate for the last 3 years (2021-2023) was -13.75%, and for the last 5 years (2019-2023) was 34.14%.

What are Viatris’s revenue streams?

Viatris's revenue streams in c 23 are Generics, and Brands. Generics generated $5.59B in revenue, accounting 36.31% of the company's total revenue, up 11.42% year-over-year. Brands generated $9.8B in revenue, accounting 63.69% of the company's total revenue, down -0.90% year-over-year.

What is Viatris’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Viatris was Brands. This segment made a revenue of $9.8B, representing 63.69% of the company's total revenue.